Usana Health Sciences (USNA) Return on Capital Employed (2011 - 2026)

Usana Health Sciences (USNA) has 16 years of Return on Capital Employed data on file, last reported at 5.71% in Q2 2026.

• Return on Capital Employed for Q2 2026 came in at 5.71%, down 368.0% year-over-year; the trailing twelve-month figure through Apr 2026 was 5.71% (down 368.0% YoY), and the FY2026 annual result was 6.07%, down 597.0% from the prior year.
• Return on Capital Employed fell to 5.71% in Q2 2026 per USNA's latest filing, from 6.17% in the prior quarter.
• Over five years, Return on Capital Employed peaked at 44.29% in Q1 2022 and troughed at 5.71% in Q2 2026.
• A 5-year average of 19.57% and a median of 18.11% in 2024 frame the typical range for Return on Capital Employed.
• The sharpest annual moves came in 2022 and 2023: Return on Capital Employed surged 519 bps in 2022, then plunged 2011 bps in 2023.
• A 5-year view of Return on Capital Employed shows it stood at 24.88% in 2022, then retreated by 25 bps to 18.68% in 2023, then tumbled by 38 bps to 11.63% in 2024, then plunged by 41 bps to 6.84% in 2025, then slipped by 16 bps to 5.71% in 2026.
• Business Quant data shows USNA's Return on Capital Employed at 5.71% in Q2 2026, 6.17% in Q1 2026, and 6.84% in Q3 2025.